Philips introduces NeuroSuite imaging system for minimally invasive neurological treatment

23 June 2014 (Last Updated June 23rd, 2014 18:30)

Netherlands-based Royal Philips has launched a new integrated interventional X-ray solution called NeuroSuite to support and improve minimally invasive image-guided neurological interventions.

Philips NeuroSuite

Netherlands-based Royal Philips has launched a new integrated interventional X-ray solution called NeuroSuite to support and improve minimally invasive image-guided neurological interventions.

The new NeuroSuite system extends treatment options by providing more effective device guidance and placement in every neuroradiology procedure.

According to the company, new interventional neurology devices such as stents and flow diverters provide new treatments for ischemic stroke or large-neck aneurysm, but their increasingly smaller designs make devices more difficult to see with X-ray imaging.

The Philips NeuroSuite addresses these challenges with a biplane interventional x-ray system that combines two new detectors.

Royal Philips's frontal FD20 detector delivers live 2D and 3D imaging to provide live navigation and immediate therapy feedback.

The smaller, lateral FD15 detector can be positioned beyond the shoulders and very close to the head, the company said.

The shorter distance and combination of detectors offer sharp, full-brain imaging at a lower X-ray dose and 3D imaging optimised for neurovascular and spine interventions.

"The new detector combination could be especially useful for stroke treatment."

Philips Healthcare Interventional X-ray general manager Ronald Tabaksblat said: "Developed in collaboration with clinical partners around the world, Philips NeuroSuite has been designed for that purpose and underpins Philips' global leadership position in live-image guidance technologies."

The new system includes Philips' AlluraClarity, which reduces radiation dose by as much as 73% without compromising image quality, and VasoCT, which visualises intracranial devices in vessel context and vessel morphology down to perforator vessels.

The company said that the first NeuroSuite system was recently installed at Karolinska University Hospital, Stockholm, Sweden, and the system is currently not available in the US.

University of Paris faculty of medicine professor Jacques Moret said: "The next step in our collaboration with Philips is the NeuroSuite bringing enhanced vessel and device visualization and full head coverage.

"The new detector combination could be especially useful for stroke treatment."


Image: NeuroSuite is designed to support and enhance minimally invasive image-guided neurological interventions. Photo: courtesy of Koninklijke Philips NV.